Answers are grounded in this paper and cite their sources.
Multidisciplinary shared medical appointments (SMAs) offer simultaneous assessment and management of medical, nutritional, psychosocial and behavioural components of a medical condition in a group setting. SMAs have been shown to improve patient satisfaction, coordination of care and social support.1 Furthermore, with a shortage of dermatologists in the United States and long wait times for appointments, SMAs improve patient access to dermatological care.2 Few studies have explored the role of this care model in patients with alopecia.3, 4 The aim of our study is to summarize patient satisfaction with a multidisciplinary SMA for patients with alopecia areata (AA) and frontal fibrosing alopecia (FFA). The SMA was offered for new patients who had been diagnosed with AA or FFA by a dermatologist or primary care physician. Patients were required to complete an intake form, sign a confidentiality consent and complete lab work before the SMA. From October 2022 to March 2023, 23 patients attended two multidisciplinary SMAs, ranging from 11 to 12 individuals in both visits. In addition to dermatology counselling, patients received lectures from a licensed nutritionist, social worker and received information regarding cranial prostheses and eyebrow camouflage related to alopecia. Each group session was 3−4 h with 30 min for a 1:1 standard alopecia consultation. Figure 1 shows the clinic flow for the SMA. Patients were asked to complete an anonymous satisfaction survey at the end. Eighteen patients completed the satisfaction survey (response rate: 78%). All returned surveys were at least 80% completed. The average age was 56.4 ± 16.7 years (range: 18−81) and all patients were female. The average overall rating for the SMA was 9.3 ± 0.9 (scale: 0 is very poor, 10 is excellent). All patients thought the information presented was useful and would recommend SMAs for hair loss to friends. Fifteen (83.3%) patients had a better understanding of how nutrition can affect their hair loss condition, 15 (83.3%) patients had a better understanding of ways to access mental healthcare and 16 (94.1%) patients had a better understanding of ways to camouflage their hair loss (Table 1). The majority of participants were comfortable in the group setting and felt they had enough privacy (88%) and personal attention (81%) during the visit (Table 1). The multidisciplinary SMA format is beneficial for both patients and physicians. For patients, the primary benefit is that they receive simultaneous education about their medical condition, treatment options and the effects of nutrition and mental health on hair loss from vetted professionals who understand the alopecia diagnoses. Low levels of certain micronutrients such as vitamin D, zinc and folate are more common in patients with AA compared to controls.5, 6 On the other hand, increased consumption of buckwheat and millet groats has been associated with FFA.7 Patients also learned about ways to conceal eyebrow and scalp hair loss. Furthermore, attendees were able to gain social support by connecting with others in the group. One patient stated that it was ‘very helpful to hear from others and how they are dealing with FFA’. SMAs improve physician efficiency by allowing the physician to see more new patients and decreasing repetition of new patient educational information.8 This care model is especially helpful for medications that require extensive counselling or lab monitoring like Janus kinase inhibitors. Limitations of this study include small sample size and possibility of selection bias. Overall, the multidisciplinary SMA format for AA and FFA resulted in high patient satisfaction and may be useful for other dermatologic conditions. Ogechi Ezemma: Writing—original draft preparation, data curation, visualization. Shivali Devjani: Writing—review and editing, data curation, visualization. Kristen J. Kelley: Writing—review and editing, data curation, visualization. Maryanne Senna: Conceptualization, methodology, supervision, writing—review and editing. M. S. is a consultant for L'Oreal, Kintor, Inmagene, Lilly, Pfizer, Abbvie, Arena and is on the advisory board for Pfizer and Lilly. The remaining authors declare no conflict to interest. Not applicable. This study was funded in part by a grant from Pfizer, Inc.
No takes yet. Share an insight, caveat, or question.
Ezemma et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: